Talphera, Inc. Common Stock

TLPHNASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
1.23 USD
↗ 0.04 (3.36%)AT CLOSE (11:59 AM EDT)
1.22
↘ 0.01 (0.81%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
1.22
↘ 0.01 (0.81%)
🟢Market: OPEN

Talphera, Inc. Common Stock (TLPH) is currently trading at $1.22. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, TLPH trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Aug 25, 2026.

Open?$1.21
High?$1.25
Low?$1.18
Prev. Close?$1.19
Volume?318.7K
Avg. Volume?288.6K
VWAP?$1.21
Rel. Volume?1.10x
Bid / Ask
Bid?$1.05 × 100
Ask?$1.45 × 100
Spread?$0.40
Midpoint?$1.25
Valuation & Ratios
Market Cap?61.8M
Shares Out?51.9M
Float?29.5M
Float %?56.8%
P/E Ratio?N/A
P/B Ratio?4.29
EPS?-$0.29
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Themes
Biotech - Drug Development›Clinical-Stage Platforms
Employees
12
Market Cap
61.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.talphera.com
Listed
2011-02-11
Address
1850 GATEWAY DRIVE
SAN MATEO, CA 94404
Phone: 650-216-3500
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
100
Piotroski F-Score?0/9Weak
Altman Z-Score?-23.46Distress
Confidence?43%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.75%Low
Short Interest?515.2K
Days to Cover?1.4
Free Float29.5M
Avg Daily Volume380.4K
Settlement Date2026-08-14
Financial Health
Current Ratio?1.79Adequate
Quick Ratio?1.79Adequate
Cash Ratio?0.07Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
42
4.29FAIR▾
P/S?
Peers
100
S&P
3
61,767.90HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.1CHEAP▾
EV/Sales?
Peers
100
S&P
3
61,025.90HIGH▾
Returns & Efficiency
ROE?
S&P
3
-104.7%WEAK▾
ROA?
S&P
3
-56.2%WEAK▾
Cash Flow & Enterprise
FCF?$-12270000
Enterprise Value?$61.0M
Fundamentals ratios updated end of day
MarketsMoversWatchlist